INFORMATION YOU CAN USE
Explore practical information and litigation updates.
LITIGATION INFORMATION · Nov 4, 2026
Australia plans to withdraw Tavneos on March 31, 2027. Learn why that date does not set U.S. treatment decisions or deadlines for liver injury claims.
Read article →
LITIGATION INFORMATION · Oct 25, 2026
Dupixent co-lead counsel news: what the October 23 Seeger announcement tells CTCL claimants about leadership, individual cases, and payment expectations.
Read article →
LITIGATION INFORMATION · Oct 13, 2026
Boston Scientific SCS MDL 3181 now lists 41 pending cases. Learn why device maker records, lead models, shocks, burns, and explant notes…
Read article →
LITIGATION INFORMATION · Oct 11, 2026
Depo-Provera settlement registration runs to Nov. 30, 2026. Learn what MDL 3140 claimants should confirm before records review and deadline questions.
Read article →
LITIGATION INFORMATION · Oct 10, 2026
Roblox MDL 3166 has a settlement master, but families still need individual cases and careful records before any resolution talks move forward.
Read article →
LITIGATION INFORMATION · Oct 9, 2026
Tavneos liver injury claims may turn on the May 2026 label update, liver-test timing, VBDS signs, and records after hospitalization or death.
Read article →
LITIGATION INFORMATION · Oct 9, 2026
New Dupixent MDL status dates show the CTCL litigation is organizing, not settling; patients should preserve biopsy and prescription records.
Read article →Start with a free case review, with no obligation.